UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Clinical manifestations and diagnosis of coronary heart disease in end-stage renal disease (dialysis)

Authors
Alfred K Cheung, MD
William L Henrich, MD, MACP
Charles A Herzog, MD
Section Editors
Jeffrey S Berns, MD
Steve J Schwab, MD
Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC
Deputy Editor
Alice M Sheridan, MD

INTRODUCTION

Cardiovascular disease (CVD) accounts for almost half the deaths of patients with end-stage renal disease (ESRD) [1-4]. Of these, approximately 20 percent can be attributed to coronary artery disease (CAD), also referred to as coronary heart disease (CHD). Patients with varying stages of chronic kidney disease (CKD), but who are not yet dialysis dependent, also have a markedly increased risk of morbidity and mortality from CVD, including CHD. (See "Patient survival and maintenance dialysis" and "Chronic kidney disease and coronary heart disease".)

This topic reviews screening, clinical manifestations, and diagnosis of stable CHD and acute coronary syndrome in ESRD patients. CHD in the general population is discussed elsewhere. (See "Coronary heart disease and myocardial infarction in young men and women" and "Screening for coronary heart disease".)

Other aspects of CHD in dialysis patients are presented elsewhere. (See "Secondary prevention of cardiovascular disease in end-stage renal disease (dialysis)" and "Risk factors and epidemiology of coronary heart disease in end-stage renal disease (dialysis)".)

STABLE CORONARY HEART DISEASE

Many of the issues concerning the presentation and evaluation of the stable ESRD patient suspected of having CHD are the same in those in the general population. (See "Screening for coronary heart disease" and "Coronary heart disease and myocardial infarction in young men and women", section on 'Clinical presentation' and "Clinical features and diagnosis of coronary heart disease in women", section on 'Clinical presentation'.)

The following sections will specifically address issues unique to dialysis patients. However, as noted in the following sections, very few randomized trials have been performed in these individuals.

          

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Fri Sep 11 00:00:00 GMT+00:00 2015.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Farias MA, McClellan W, Soucie JM, Mitch WE. A prospective comparison of methods for determining if cardiovascular disease is a predictor of mortality in dialysis patients. Am J Kidney Dis 1994; 23:382.
  2. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10:1606.
  3. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108:2154.
  4. Cheung AK, Sarnak MJ, Yan G, et al. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int 2004; 65:2380.
  5. Goldsmith DJ, Covic A. Coronary artery disease in uremia: Etiology, diagnosis, and therapy. Kidney Int 2001; 60:2059.
  6. Choi MJ, Kim JK, Kim SG, et al. Left atrial volume index is a predictor of silent myocardial ischemia in high-risk patients with end-stage renal disease. Int J Cardiovasc Imaging 2013; 29:1433.
  7. Krane V, Heinrich F, Meesmann M, et al. Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. Clin J Am Soc Nephrol 2009; 4:394.
  8. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342:1077.
  9. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 62:e147.
  10. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45:S1.
  11. Gill JS, Ma I, Landsberg D, et al. Cardiovascular events and investigation in patients who are awaiting cadaveric kidney transplantation. J Am Soc Nephrol 2005; 16:808.
  12. https://clinicaltrials.gov/ct2/show/NCT01985360.
  13. Elsner D. How to diagnose and treat coronary artery disease in the uraemic patient: an update. Nephrol Dial Transplant 2001; 16:1103.
  14. Schmidt A, Stefenelli T, Schuster E, Mayer G. Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy. Am J Kidney Dis 2001; 37:56.
  15. Sharma R, Pellerin D, Gaze DC, et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant 2005; 20:2207.
  16. Wang LW, Fahim MA, Hayen A, et al. Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database Syst Rev 2011; :CD008691.
  17. Herzog CA, Shroff GR. Atherosclerotic versus nonatherosclerotic evaluation: the Yin and Yang of cardiovascular imaging in advanced chronic kidney disease. JACC Cardiovasc Imaging 2014; 7:729.
  18. Herzog CA, Marwick TH, Pheley AM, et al. Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis 1999; 33:1080.
  19. http://www2.kidney.org/professionals/KDOQI/guidelines_cvd/guide6.htm (Accessed on June 05, 2015).
  20. Go AS, Bansal N, Chandra M, et al. Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease. J Am Coll Cardiol 2011; 58:1600.
  21. Herzog CA. How to manage the renal patient with coronary heart disease: the agony and the ecstasy of opinion-based medicine. J Am Soc Nephrol 2003; 14:2556.
  22. Herzog CA, Littrell K, Arko C, et al. Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation 2007; 116:1465.
  23. Shroff GR, Frederick PD, Herzog CA. Renal failure and acute myocardial infarction: clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. A collaborative project of the United States Renal Data System/National Institutes of Health and the National Registry of Myocardial Infarction. Am Heart J 2012; 163:399.
  24. Fox CS, Muntner P, Chen AY, et al. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. Circulation 2010; 121:357.
  25. Szummer K, Lundman P, Jacobson SH, et al. Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register. J Intern Med 2010; 268:40.
  26. Surana SP, Riella LV, Keithi-Reddy SR, et al. Acute coronary syndrome in ESRD patients. Kidney Int 2009; 75:558.